Health Care

Trump administration awards contract to make COVID-19 drugs in U.S

Trump administration awards contract to make COVID-19 drugs in U.S”

Many of these medicines are in shortage and have previously been imported.

The United States will announce today that it has signed a US$354 million (RM1.54 billion) contract with a company to make generic medicines and pharmaceutical ingredients in the country needed to treat Covid-19, the New York Times reported late yesterday.

The administration has been looking to build up the ability to produce drugs and their raw materials in the United States after the global pandemic exposed the industry's dependence on China and India for its supply chain. He told CBS News in March that he had been working on an executive action that would tighten domestic procurement by requiring federal agencies to buy US -made pharmaceuticals and medical equipment.

"For far too long, we've relied on foreign manufacturing and supply chains for our most important medicines and active pharmaceutical ingredients while placing America's health, safety, and national security at grave risk", he said.

Phlow, which was incorporated in January, said the contract will help it contribute to a national stockpile of pharmaceutical ingredients for essential medicines.

The four-year contract, with an additional $458 million included as potential options, is a move by the administration to reduce the country's dependency on foreign nations to support its drug supply chain.

"This contract is a start" in addressing the supply chain problems causing drug shortages, said Jeff Francer, CEO of the Association for Accessible Medicines, the trade group for US makers of generic drugs.

More news: United States border closure extended 30 more days, Trudeau says

The company submitted a proposal on drug manufacturing in response to an open request from the Biomedical Advanced Research and Development Authority, one of the HHS agencies overseeing COVID-19 vaccine and drug development, he said.

Under the contract, Phlow will work with private-sector partners to produce pharmaceutical ingredients used in medicines needed to treat COVID-19 patients, many of which are produced overseas.

The partnership comes amid concerns from Trump administration officials and lawmakers over supply chains spread around the world for critical products, as numerous pharmaceutical ingredients necessary for medications to help treat COVID-19 are now made internationally, specifically in China and India.

Edwards said the company plans to create about 350 new jobs and will build "multiple" facilities next to an existing AMPAC-owned pharmaceutical plant in Petersburg, just south of Richmond.

All pharmaceutical products by Phlow will be made on American soil, according to the company's website.

Phlow is partnering with Civica Rx, Virginia Commonwealth University's Medicines for All Institute, and AMPAC Fine Chemicals. Edwards said he was never a member of the company's pricing committee and said the drug saved thousands of lives.



Like this

loading...
loading...

Latest


20 May 2020
Facebook and Instagram roll out Shops, turning business profiles into storefronts
This week, Facebook released a study that claimed one-third of small businesses have closed during the pandemic . The real significance of Tuesday's announcement, though, may be Zuckerberg's personal involvement in the effort.

20 May 2020
Kristin Cavallari announces she has QUIT her reality show Very Cavallari
Kristin Cavallari announced on Tuesday that she's ending her E! reality show " Very Cavallari " after three seasons. Raegan Agee, who worked for Cavallari through season 2, was eventually fired as well.

20 May 2020
Why the Michael Flynn case matters in the fight against IL corruption
The request was filed after months of President Trump and his allies cheering Flynn on in his fight against the prosecutors. Court of Appeals for the District of Columbia Circuit order District Judge Emmet Sullivan to grant a request by the U.S.

20 May 2020
Steve Carell Launches Rockets in New SPACE FORCE Trailer
Starring Steve Carell in the lead role as the leader of Space Force and is brought by the makers of his hit show The Office . You got to know him as Michael Scott, but when you see him in Space Force you'll see a whole new side of Carell.

20 May 2020
Apple acquires VR company NextVR
Apple has declined to disclose the amount of the deal, whereas 9to5Mac estimates the acquisition was worth $ 100 million . The acquisition may help Apple's development of VR and AR headsets with accompanying software and content.

20 May 2020
Justin Bieber Fires Back At Tekashi 69 Due To Billboard Allegations!
These were the details of the news Bollywood News - Grande , Bieber respond to rapper's accusation of "buying". for this day. A separate post made reference to "6 credit cards used to buy 60,000 copies [of "Stuck with U"] in the last hour".

20 May 2020
Pompeo rejected request for interview from inspector general on Saudi arms sales
The secretary of state said Mr Linick was sacked for " undermining " the state department, though he did not give further details. Trump said he believes inspectors general appointed by his predecessor should "generally" be replaced throughout the government.

20 May 2020
Joe Biden to host virtual rally in Milwaukee Wednesday
He said I was xenophobic. 61% of voters say China is "unfriendly" or an "enemy", up 9 points since January. They said you don't need it, it's too much, it's too severe, and they turned out to be wrong", he said.

20 May 2020
Coronavirus: Trump says he is taking unproven drug hydroxychloroquine
"I'm not but I would never begrudge any American taking the advice of their physician", he told Fox News' Kristin Fisher. The President said he had started taking it "a couple of weeks ago" because "I've heard a lot of good stories".

20 May 2020
Moderna's COVID-19 vaccine trial: Biggest hurdles are ahead
NY time Monday, its stock offering at 4:18 p.m. (18 minutes after the stock market closed) and the offering price at 10:32 p.m. The findings are based on results from the first eight people who each received two doses of the vaccine, starting in March.